Biltmore Wealth Management LLC Sells 462 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Biltmore Wealth Management LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.1% during the third quarter, Holdings Channel reports. The fund owned 2,399 shares of the company’s stock after selling 462 shares during the period. HCA Healthcare makes up approximately 0.4% of Biltmore Wealth Management LLC’s holdings, making the stock its 23rd biggest holding. Biltmore Wealth Management LLC’s holdings in HCA Healthcare were worth $975,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. CreativeOne Wealth LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $231,000. New Mexico Educational Retirement Board grew its stake in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the period. Kingswood Wealth Advisors LLC bought a new position in HCA Healthcare during the first quarter worth about $566,000. Teachers Retirement System of The State of Kentucky increased its stake in shares of HCA Healthcare by 15.6% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock valued at $53,922,000 after acquiring an additional 26,919 shares during the last quarter. Finally, Brave Warrior Advisors LLC grew its holdings in HCA Healthcare by 182.1% during the fourth quarter. Brave Warrior Advisors LLC now owns 3,873 shares of the company’s stock valued at $1,048,000 after purchasing an additional 2,500 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HCA. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. UBS Group increased their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Finally, Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Stock Performance

Shares of HCA traded up $1.61 during mid-day trading on Friday, reaching $394.07. The company’s stock had a trading volume of 787,871 shares, compared to its average volume of 1,131,020. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $409.42. The business has a 50-day simple moving average of $384.62 and a two-hundred day simple moving average of $345.49. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $103.21 billion, a P/E ratio of 19.64, a PEG ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned $4.29 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s dividend payout ratio is 13.16%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.